Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6P7G

The co-crystal structure of BRAF(V600E) with PHI1

Summary for 6P7G
Entry DOI10.2210/pdb6p7g/pdb
DescriptorSerine/threonine-protein kinase B-raf, 3-[(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-[4-({[2-(morpholin-4-yl)ethyl]amino}methyl)-3-(trifluoromethyl)phenyl]benzamide, 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID, ... (4 entities in total)
Functional Keywordskinase, inhibitor, cancer, melanoma, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceHomo sapiens (Human)
Total number of polymer chains4
Total formula weight137468.30
Authors
Agianian, B.,Gavathiotis, E. (deposition date: 2019-06-05, release date: 2020-09-23, Last modification date: 2024-03-13)
Primary citationCotto-Rios, X.M.,Agianian, B.,Gitego, N.,Zacharioudakis, E.,Giricz, O.,Wu, Y.,Zou, Y.,Verma, A.,Poulikakos, P.I.,Gavathiotis, E.
Inhibitors of BRAF dimers using an allosteric site.
Nat Commun, 11:4370-4370, 2020
Cited by
PubMed: 32873792
DOI: 10.1038/s41467-020-18123-2
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.65 Å)
Structure validation

218853

PDB entries from 2024-04-24

PDB statisticsPDBj update infoContact PDBjnumon